Statin use and longitudinal changes in quantitative MRI-based biomarkers of thigh muscle quality: data from Osteoarthritis Initiative

Bahram Mohajer, Kamyar Moradi, Ali Guermazi, Mahsa Dolatshahi, Frank W. Roemer, Hamza A. Ibad, Ghazaal Parastooei, Philip G. Conaghan, Bashir A. Zikria, Mei Wan, Xu Cao, Joao A.C. Lima, Shadpour Demehri

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To assess whether changes in MRI-based measures of thigh muscle quality associated with statin use in participants with and without/at-risk of knee osteoarthritis. Methods: This retrospective cohort study used data from the Osteoarthritis Initiative study. Statin users and non-users were matched for relevant covariates using 1:1 propensity-score matching. Participants were further stratified according to baseline radiographic knee osteoarthritis status. We used a validated deep-learning method for thigh muscle MRI segmentation and calculation of muscle quality biomarkers at baseline, 2nd, and 4th visits. Mean difference and 95% confidence intervals (CI) in longitudinal 4-year measurements of muscle quality biomarkers, including cross-sectional area, intramuscular adipose tissue, contractile percent, and knee extensors and flexors maximum and specific contractile force (force/muscle area) were the outcomes of interest. Results: After matching, 3772 thighs of 1910 participants were included (1886 thighs of statin-users: 1886 of non-users; age: 62 ± 9 years (average ± standard deviation), range: 45–79; female/male: 1). During 4 years, statin use was associated with a slight decrease in muscle quality, indicated by decreased knee extension maximum (mean-difference, 95% CI: − 1.85 N/year, − 3.23 to − 0.47) and specific contractile force (− 0.04 N/cm2/year, − 0.07 to − 0.01), decreased thigh muscle contractile percent (− 0.03%/year, − 0.06 to − 0.01), and increased thigh intramuscular adipose tissue (3.06 mm2/year, 0.53 to 5.59). Stratified analyses showed decreased muscle quality only in participants without/at-risk of knee osteoarthritis but not those with established knee osteoarthritis. Conclusions: Statin use is associated with a slight decrease in MRI-based measures of thigh muscle quality over 4 years. However, considering statins’ substantial cardiovascular benefits, these slight muscle changes may be relatively less important in overall patient care.

Original languageEnglish (US)
Pages (from-to)683-695
Number of pages13
JournalSkeletal Radiology
Volume53
Issue number4
DOIs
StatePublished - Apr 2024

Keywords

  • Deep learning
  • Knee osteoarthritis
  • MRI
  • Muscle quality
  • Statin

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Statin use and longitudinal changes in quantitative MRI-based biomarkers of thigh muscle quality: data from Osteoarthritis Initiative'. Together they form a unique fingerprint.

Cite this